S&P 500   3,325.13 (+0.56%)
DOW   27,142.44 (+1.17%)
QQQ   270.97 (+0.22%)
AAPL   437.34 (-0.30%)
MSFT   212.46 (-0.39%)
FB   249.95 (+0.05%)
GOOGL   1,480.47 (+0.49%)
AMZN   3,185.69 (+1.49%)
NVDA   450.97 (+0.41%)
CGC   19.17 (-0.78%)
BABA   264.03 (+0.70%)
TSLA   1,485.88 (-0.08%)
MU   50.98 (-0.62%)
GE   6.15 (+0.16%)
AMD   85.43 (+0.46%)
T   29.81 (-0.67%)
F   6.96 (+1.46%)
ACB   10.69 (-0.37%)
GILD   69.47 (-1.99%)
NFLX   503.86 (-1.13%)
DIS   128.25 (+9.34%)
BAC   25.35 (+1.36%)
BA   173.35 (+5.02%)
S&P 500   3,325.13 (+0.56%)
DOW   27,142.44 (+1.17%)
QQQ   270.97 (+0.22%)
AAPL   437.34 (-0.30%)
MSFT   212.46 (-0.39%)
FB   249.95 (+0.05%)
GOOGL   1,480.47 (+0.49%)
AMZN   3,185.69 (+1.49%)
NVDA   450.97 (+0.41%)
CGC   19.17 (-0.78%)
BABA   264.03 (+0.70%)
TSLA   1,485.88 (-0.08%)
MU   50.98 (-0.62%)
GE   6.15 (+0.16%)
AMD   85.43 (+0.46%)
T   29.81 (-0.67%)
F   6.96 (+1.46%)
ACB   10.69 (-0.37%)
GILD   69.47 (-1.99%)
NFLX   503.86 (-1.13%)
DIS   128.25 (+9.34%)
BAC   25.35 (+1.36%)
BA   173.35 (+5.02%)
S&P 500   3,325.13 (+0.56%)
DOW   27,142.44 (+1.17%)
QQQ   270.97 (+0.22%)
AAPL   437.34 (-0.30%)
MSFT   212.46 (-0.39%)
FB   249.95 (+0.05%)
GOOGL   1,480.47 (+0.49%)
AMZN   3,185.69 (+1.49%)
NVDA   450.97 (+0.41%)
CGC   19.17 (-0.78%)
BABA   264.03 (+0.70%)
TSLA   1,485.88 (-0.08%)
MU   50.98 (-0.62%)
GE   6.15 (+0.16%)
AMD   85.43 (+0.46%)
T   29.81 (-0.67%)
F   6.96 (+1.46%)
ACB   10.69 (-0.37%)
GILD   69.47 (-1.99%)
NFLX   503.86 (-1.13%)
DIS   128.25 (+9.34%)
BAC   25.35 (+1.36%)
BA   173.35 (+5.02%)
S&P 500   3,325.13 (+0.56%)
DOW   27,142.44 (+1.17%)
QQQ   270.97 (+0.22%)
AAPL   437.34 (-0.30%)
MSFT   212.46 (-0.39%)
FB   249.95 (+0.05%)
GOOGL   1,480.47 (+0.49%)
AMZN   3,185.69 (+1.49%)
NVDA   450.97 (+0.41%)
CGC   19.17 (-0.78%)
BABA   264.03 (+0.70%)
TSLA   1,485.88 (-0.08%)
MU   50.98 (-0.62%)
GE   6.15 (+0.16%)
AMD   85.43 (+0.46%)
T   29.81 (-0.67%)
F   6.96 (+1.46%)
ACB   10.69 (-0.37%)
GILD   69.47 (-1.99%)
NFLX   503.86 (-1.13%)
DIS   128.25 (+9.34%)
BAC   25.35 (+1.36%)
BA   173.35 (+5.02%)
Log in

NASDAQ:BLCMBellicum Pharmaceuticals Earnings Date, Estimates & History

$7.40
+0.23 (+3.21 %)
(As of 08/5/2020 12:54 PM ET)
Add
Compare
Today's Range
$7.15
Now: $7.40
$7.40
50-Day Range
$6.53
MA: $7.74
$9.03
52-Week Range
$3.32
Now: $7.40
$27.90
Volume497 shs
Average Volume44,333 shs
Market Capitalization$37.37 million
P/E RatioN/A
Dividend YieldN/A
Beta2.1

Earnings

Bellicum Pharmaceuticals (NASDAQ:BLCM) Earnings Information

Bellicum Pharmaceuticals last issued its earnings data on May 7th, 2020. The biopharmaceutical company reported $1.09 earnings per share (EPS) for the quarter, beating the consensus estimate of ($2.73) by $3.82. Bellicum Pharmaceuticals has generated ($19.91) earnings per share over the last year. Bellicum Pharmaceuticals has confirmed that its next quarterly earnings report will be published on Thursday, August 6th, 2020. Bellicum Pharmaceuticals will be holding an earnings conference call on Thursday, August 6th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

Bellicum Pharmaceuticals Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Bellicum Pharmaceuticals (NASDAQ:BLCM) Earnings Estimates

Current Year EPS Consensus Estimate: $-9.32 EPS
Next Year EPS Consensus Estimate: $-13 EPS

Bellicum Pharmaceuticals (NASDAQ BLCM) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
8/6/2020
(Confirmed)
      Register (After Market Closes)
5/7/2020Q1 2020($2.73)$1.09$1.09Transcript
3/12/202012/31/2019($4.00)($5.82)($0.06)$0.30 million$5.13 millionTranscript
11/6/2019Q3 2019($5.70)($5.80)($0.48)$0.30 million$0.10 millionN/A
8/5/2019Q2 2019($5.40)($5.80)($0.58)$0.23 million$1.39 millionN/A
5/7/20193/31/2019($8.30)($5.50)($0.55)$0.20 million$0.52 millionN/A
3/12/201912/31/2018($5.80)($6.30)($0.63)$0.18 million$0.31 millionTranscript
11/6/2018Q3($5.82)($5.50)($0.55)$0.07 million$0.29 millionN/A
8/7/2018Q2 2018($5.50)($6.00)($0.60)$0.08 million$0.36 millionN/A
5/8/2018Q1 2018($7.04)($6.80)($0.68)$0.08 million$0.15 millionN/A
3/13/2018Q4 2017($6.90)($6.10)($0.56)$0.08 million($0.07) millionN/A
11/7/2017Q3 2017($7.40)($7.10)($0.71)$0.03 million$0.13 millionN/A
8/8/2017Q2 2017($6.50)($7.40)($0.74)$0.08 millionListen
5/8/2017Q1 2017($7.04)($8.00)($0.80)$0.09 million$0.13 millionN/A
3/13/2017Q4 2016($7.10)($7.40)($0.74)$0.10 million$0.08 millionN/A
11/9/2016Q3($6.30)($6.60)($0.66)$0.09 million$0.11 millionN/A
8/8/2016Q216($5.70)($6.10)($0.61)$0.10 million$0.10 millionListen
5/9/2016Q1 2016($5.10)($5.60)($0.56)$0.50 million$0.09 millionN/A
3/14/2016Q415($4.40)($6.30)($0.63)$2.00 million$0.03 millionListen
11/9/2015Q315($3.80)($5.10)($0.51)$0.18 million$0.06 millionN/A
8/13/2015Q215($4.90)($4.00)($0.40)$0.23 million$0.08 millionListen
5/11/2015Q1($2.20)($3.00)($0.30)$0.50 million$0.11 millionN/A
3/11/2015Q4($117.90)($20.20)$14.95$0.60 million$0.02 millionListen
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 8/5/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.